Taysha Gene Therapies Inc (TSHA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2021 | 12-2020 | 09-2020 | 06-2020 | 03-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 228,684 | 251,253 | 278,634 | 0 | 0 |
| Other current assets | 128 | 0 | 0 | 0 | 0 |
| TOTAL | $239,629 | $257,879 | $279,238 | $0 | $0 |
| Non-Current Assets | |||||
| PPE Net | 2,497 | 287 | 28 | N/A | N/A |
| Other Non-Current Assets | 703 | 715 | 0 | 0 | 0 |
| TOTAL | $3,200 | $1,002 | $28 | $N/A | $N/A |
| Total Assets | $242,829 | $258,881 | $279,266 | $0 | $0 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 4,083 | 1,994 | 8,837 | 0 | 0 |
| Accrued Expenses | 14,875 | 5,135 | 2,727 | 0 | 0 |
| Other current liabilities | N/A | N/A | 60 | 0 | 0 |
| TOTAL | $18,958 | $7,129 | $11,624 | $0 | $0 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 999 | 450 | 0 | 0 | 0 |
| TOTAL | $999 | $450 | $N/A | $N/A | $N/A |
| Total Liabilities | $19,957 | $7,579 | $11,624 | $0 | $0 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 37,917 | 37,761 | 37,761 | N/A | N/A |
| Retained earnings | -93,150 | -61,126 | -42,808 | 0 | 0 |
| TOTAL | $222,872 | $251,302 | $267,642 | $0 | $0 |
| Total Liabilities And Equity | $242,829 | $258,881 | $279,266 | $0 | $0 |